Global Trade Alert
Global Trade Alert

Back to state act

United States of America: Agreement with EMD Serono on Most-Favored-Nation drug pricing and tariff exemption

Description

On 16 October 2025, the U.S. Administration announced an agreement with EMD Serono. Under the agreement, EMD Serono will be exempt from Section 232 tariffs on pharmaceutical products, in exchange for ...

Sign in to see full description

Intervention Details

Intervention Type

Local operations incentive

MAST Chapter

I: Trade-related investment measures

Implementation date

16 Oct 2025

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 6 products

Threads

See all

This intervention is not part of any Thread yet.